Advertisment Nexovas Cilnidipine
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:151

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (273 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   References
   Article Tables

 Article Access Statistics
    Viewed3199    
    Printed71    
    Emailed0    
    PDF Downloaded446    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
COMMENTARY
Year : 2015  |  Volume : 25  |  Issue : 3  |  Page : 133-135
 

Prevalence of chronic kidney disease in India - Where are we heading?


Chief Consultant, Indian Armed Forces, New Delhi, India

Date of Web Publication13-May-2015

Correspondence Address:
P P Varma
Indian Armed Forces, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 26060360

Rights and PermissionsRights and Permissions



How to cite this article:
Varma P P. Prevalence of chronic kidney disease in India - Where are we heading?. Indian J Nephrol 2015;25:133-5

How to cite this URL:
Varma P P. Prevalence of chronic kidney disease in India - Where are we heading?. Indian J Nephrol [serial online] 2015 [cited 2019 Jun 26];25:133-5. Available from: http://www.indianjnephrol.org/text.asp?2015/25/3/133/148304


With increasing life expectancy and prevalence of life style diseases, US has seen a 30% increase in prevalence of chronic kidney disease (CKD) in the last decade. [1] Unfortunately, from India there is no longitudinal study and limited data on the prevalence of CKD.

In western countries, diabetes and hypertension account for over 2/3 rd of the cases of CKD. [2] In India too, diabetes and hypertension today account for 40-60% cases of CKD. [3] As per recent Indian Council of Medical Research data, prevalence of diabetes in Indian adult population has risen to 7.1%, (varying from 5.8% in Jharkhand to 13.5% in Chandigarh) and in urban population (over the age of 40 years) the prevalence is as high as 28%. [4],[5] Likewise the reported prevalence of hypertension in the adult population today is 17% (14.8% from rural and 21.4% from urban belt). A similar prevalence of 17.4% has been reported by Panesar et al. (in the age group of 20-59 years) even from slum-resettlement colony of Delhi. [6],[7] With rising prevalence of these diseases in India, prevalence of CKD is expected to rise, and obviously this is the key target population to address.

A study was published in a recent issue of the journal from a rural belt of Karnataka. [8] The population had a mean age of 39.88 ± 15.87 years with 3.82% prevalence of diabetes and 33.62% of hypertension. Authors found 6.3% prevalence of CKD stage 3; which is the highest reported till date by any Indian worker. It is disturbing to note, the high prevalence of hypertension in a rural setting where over 75% population had normal or low body mass index. In comparison to most other published studies from India [Table 1], the present study population is younger and even the prevalence of diabetes is low but surprisingly despite that prevalence of stage 3 CKD is reported to be higher (6.3%). It is disturbing to see the rising prevalence of hypertension and CKD in rural belts. Possibly with shifting population the difference between urban and rural areas is getting blurred. Undoubtedly, we need more Indian data to validate these findings.
Table 1: Prevalence of CKD- Indian Data

Click here to view


Such data also raises a suspicion/possibility of an entity like 'CKD of unknown etiology-CKDu [9] in this area, like in certain areas of Sri Lanka and Andhra Pradesh. One is not sure of the underlying cause for CKDu, though suspected agents are cadmium, fluoride, arsenic, pesticides, etc. Renal histology in these cases shows chronic tubule-interstitial nephritis. One seriously needs to think about the existence of such entity in this belt.

Modi and Jha [10] reported an age-adjusted incidence of end-stage kidney disease (ESKD) as 229/million population. This is more than double of what has been believed (100/million) over a long time. Was the previous data not very exact or the prevalence has actually risen due to increased longevity and life style diseases, is the point for debate? This study however addressed only stage 5D.

As one can see from published Indian studies, population screened, and criteria used for CKD diagnosis are different by different workers. Agarwal et al. [11] studied south Delhi urban population and reported stage 3 prevalence of 0.785%. They used s creatinine cut off of over 1.8 mg/dl, done on two occasions (approximate 12 weeks apart) as the defining criteria. Study has limitations; (i) CKD diagnosis is not based on glomerular filtration rate (GFR) (ii) patients with proteinuria have not been included (iii) creatinine cut off is high; hence the reported figure is much lower than reported by other Indian studies.

Singh et al. [12] studied urban and semiurban population of Delhi. They had 31.2% hypertensives and 7.3% diabetics in the screened population. Based on dipstick proteinuria and GFR calculation by modification of diet in renal disease (MDRD) equation they found 4.2% population to be suffering from stage 3 CKD. However, they didn't repeat the proteinuria testing and study didn't address CKD stage 1 and 2.

We studied CKD prevalence in healthy government employees and their families. Inclusion criteria differed as we didn't include population with known diabetes, hypertension or renal disease. We tested for microalbumin uria to pick up early stages of CKD and calculated GFR by MDRD and CKD-EPI equations. Our population was relatively younger (35.64 ± 8.72 years) but diverse. 13-15% were diagnosed to have undiagnosed hypertension and 1.53% diabetes. We found prevalence of CKD as 13-15.04% with stage 1, 2 and 3 as 6.62%, 5.40% and 3.02% respectively. [13] The study findings are similar to National Health and Nutrition Examination Survey data suggesting that we are no different from the western world.

In a recently published Screening and Early Evaluation of Kidney Disease study [14] the mean age of the population was 45.22 ± 15.2 years, and any adult could participate in the study. They performed dipstick proteinuria, and GFR calculation was with CKD-EPI equation. They found the prevalence of CKD as 17.2% with stage 1, 2, 3, 4, 5 as 7%, 4.3%, 4.3%, 0.8% and 0.8% respectively. 43.1% of their cohort had hypertension, and 18.8% had diabetes; a figure that is not a true representation of Indian population.

What one gathers from published data from India is that we are no different from US population in the prevalence of CKD. Like the present study suggests that even the difference between the prevalence of CKD between rural and urban India is getting blurred. Today life expectancy of an Indian has increased from 41.38 years (in 1960) to 66 years (2013) [15] and prevalence of diabetes and hypertension is steadily rising. Therefore like in western world prevalence of CKD is expected to rise with the passage of time.

However when doing such epidemiological studies we need to formalise few issues (i) creatinine estimation should be standardized, which is not the case so far in India (ii) in absence of co-morbidities should an aging kidney be categorized as CKD and (iii) as suggested by KDIGO, till we have a correction factor for Indians, CKD-EPI equation should be used. A recent study from India compared GFR by Gate's method, plasma clearance method and eGFR by MDRD equation. They found Gate's method better than eGFR but there was poor correlation of radionucleide clearance method (akin to the gold standard) with Gate's method and MDRD equation. [16]

Though a minority of CKD patients reach ESKD (0.15-0.20%/year over next 10-25 years), this population is 10-100 times vulnerable for cardiovascular (CV) events. Therefore, it is important to identify them and have preventive strategy for CV events in place. [17] Should screening be universal or targeted to high-risk groups? (i.e. diabetics, hypertensives, CVD patients and those with family h/o renal disease etc.). It is a known fact that over 50% of diabetics and hypertensives are not aware that they are harboring the disease, therefore if we target the high risk population than only half the patients are likely to be missed; hence some researchers advocate universal screening. [18] But keeping the economics in mind even for developed countries universal screening is not cost-effective, therefore, it may be prudent to have targeted screening for CKD. [19] But whatever policy one follows, there is little doubt about that there is an urgent need to have appropriate social and political strategy for prevention of CKD.

 
  References Top

1.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47.  Back to cited text no. 1
    
2.
Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Physician 2005;72:1723-32.  Back to cited text no. 2
    
3.
Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, et al. What do we know about chronic kidney disease in India: First report of the Indian CKD registry. BMC Nephrol 2012;13:10.  Back to cited text no. 3
    
4.
Raman R, Ganesan S, Pal SS, et al. Prevalence and risk factors for diabetic retinopathy in rural India. BMJ Open Diabetes Res Care 2014;2:e0000005.  Back to cited text no. 4
    
5.
Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-7.  Back to cited text no. 5
    
6.
Panesar S, Chaturvedi S, Saini NK, et al. Prevalence and Predictors of hypertension among residents aged 20-59 years of a slum resettlement colony of Delhi, India. WHO South East Asia J Public Health 2013;2:83-7.  Back to cited text no. 6
    
7.
Bhadoria AS, Kasar PK, Toppo NA, Bhadoria P, Pradhan S, Kabirpanthi V. Prevalence of hypertension and associated cardiovascular risk factors in Central India. J Family Community Med 2014;21:29-38.  Back to cited text no. 7
    
8.
Anupama YJ, Uma G. Prevalence of chronic kidney disease among adults in a rural community in South India: Results from the kidney disease screening (KIDS) project. Indian J Nephrol 2014;24:214-21.  Back to cited text no. 8
[PUBMED]  Medknow Journal  
9.
Almaguer M, Herrera R, Orantes CM. Chronic kidney disease of unknown etiology in agricultural communities. MEDICC Rev 2014;16:9-15.  Back to cited text no. 9
    
10.
Modi GK, Jha V. The incidence of end-stage renal disease in India: A population-based study. Kidney Int 2006;70:2131-3.  Back to cited text no. 10
    
11.
Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant 2005;20:1638-42.  Back to cited text no. 11
    
12.
Singh NP, Ingle GK, Saini VK, Jami A, Beniwal P, Lal M, et al. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and Modification of Diet in Renal Disease equation: An observational, cross-sectional study. BMC Nephrol 2009;10:4.  Back to cited text no. 12
    
13.
Varma PP, Raman DK, Ramakrishnan TS, Singh P, Varma A. Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India. Nephrol Dial Transplant 2010;25:3011-7.  Back to cited text no. 13
    
14.
Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol 2013;14:114.  Back to cited text no. 14
    
15.
Life expectancy at birth - Male (years) 2013 Country Ranks, By Rank SOURCE: CIA World Factbook; 2013.  Back to cited text no. 15
    
16.
Prasad N, Barai S, Gambhir S, Parasar DS, Ora M, Gupta A, et al. Comparison of glomerular filtration rate estimated by plasma clearance method with modification of diet in renal disease prediction equation and Gates method. Indian J Nephrol 2012;22:103-7.  Back to cited text no. 16
[PUBMED]  Medknow Journal  
17.
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006;17:2034-47.  Back to cited text no. 17
    
18.
Remuzzi G, Weening JJ. Albuminuria as early test for vascular disease. Lancet 2005;365:556-7.  Back to cited text no. 18
    
19.
Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 2003;290:3101-14.  Back to cited text no. 19
    



 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07